The U.S. Food and Drug Administration announced in an October 7, 2026 court filing that it expects to complete its mifepristone safety review data collection by mid-December 2026, with a final report expected by March 2027

From the articleAbortion drug safety review will be completed by March, US FDA says | ReutersAlso in FDA says its safety review of abortion pill will continue into next year | CNN, FDA says its review of abortion pill will continue into next year, FDA says its review of abortion pill will continue into next year, FDA says it will complete safety review of abortion pill in March, FDA's abortion pill safety review continuing into next year angers abortion rights opponents, DA Says It Won't Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety Concerns